2815
The Next Step After ICS/LABA
Saturday, March 1, 2014: 4:45 PM-6:00 PM
Convention Center, Upper Level, Room 30ABCDE
1.25 CME/ 1.50 CE
Moderator:
Harold S. Nelson , MD FAAAAI
Learning Objectives:
  1. List the evidence supporting the use of anticholinergic therapy in refractory asthma
  2. Review the evidence supporting the use of a small particle ICS over conventional ICS molecules
  3. Discuss recent evidence supporting the use of omalizumab treatment in difficult asthma
4:45 PM
The Case for Anti-Cholinergics
Brian J. Lipworth, MD
Handouts
  • Lipworth handout 2815 .pptx.pdf (245.2 kB)
  • 5:00 PM
    The Case for Fine Particle ICS
    Richard J. Martin, MD
    5:15 PM
    The Case for Omalizumab
    Thomas B. Casale, MD FAAAAI
    5:30 PM
    Question & Answer
    See more of: Q & A Workshop